Pre-clinical development of novel immune therapy for paediatric cancers
Recipient: Dr Alla Dolnikov, Sydney Children’s Hospital, Randwick
The goal of this project is to investigate a novel treatment that will overcome the current limitations of immune cellular therapy to achieve long-lasting results and avoid relapse.
"[In clinical testing] we’ve seen a response rate up to 90 per cent for certain types of leukaemia and lymphoma,” she said. “It has been particularly effective in the paediatric cohort, in kids with leukaemia and lymphoma.” - Dr Alla Dolnikov, Sydney Children’s Hospital, Randwick